Skip to content

Our Science
Medical Professionals
- Overview
- HCP Resources
Investors & Media
Patients & Advocacy
Who We Are
Contact

Single Arm Phase II Study of Avutometinib and Defactinib in Advanced or Recurrent Mesonephric or Mesonephric-like (MLA) Gynecologic Cancer: Interim Results

Single Arm Phase II Study of Avutometinib and Defactinib in Advanced or Recurrent Mesonephric or Mesonephric-like (MLA) Gynecologic Cancer: Interim Results

Terms of Use
Copyright Statement
Privacy Policy
Contact
Sitemap

Twitter
Linkedin

© 2025 Verastem, Inc. All Rights Reserved.